Proton Therapy 麻豆原创 Outlook - Global Analysis | 麻豆原创 Research Reports庐 Inc.

You are here: 麻豆原创 Catalog Pharma & Healthcare Therapeutic Oncology Medical Devices Healthcare

Proton Therapy 麻豆原创 Outlook - Global Analysis

麻豆原创 Research Report Summary

Proton Therapy 麻豆原创 Outlook - Global Analysis report is published on October 3, 2016 and has 163 pages in it. This market research report provides information about Oncology, Therapeutic, Medical Devices, Healthcare, Pharma & Healthcare industry. It covers Global market data and forecasts. It is priced starting at USD 1,490.00 for Single User License (PDF) which allows one person to use this report.

Please read the description and table of contents of this research report given below to check whether it meets your research requirements. If not, then please do not hesitate to contact us using "Report Enquiry" form given below. We can customize this research report or suggest a new fully customized market research report to meet your research goals and data requirements.

Proton Therapy 麻豆原创 Outlook - Global Analysis

Printer version

Send by email

Publication ID:听

IGT1016002

Publication Date:听

October 3, 2016

笔补驳别蝉:听

163

笔耻产濒颈蝉丑别谤:听

iGATE

颁辞耻苍迟谤颈别蝉:听

Global

USD 1,490.00

Pay By Invoice

If you wish to purchase this report using bank/wire transfer against an invoice, please fill your details using request invoice form given below.

Globally Trusted Brand

We help executives from firms听to Start-ups听with their market research needs thus听we can help you too.听

Secure Checkout

You can shop confidently as your online payments are processed using PCI DSS compliant secure payment gateways on our website.

Frequently Asked Questions

If you have any pre-sales听questions related to this report please let us know using the "Report Enquiry" form below. This will help us provide you听with answers听so that you can purchase with confidence. If you wish to read about frequently asked questions by our customers please visit our .

Tabs

Description

Proton therapy is an advanced form of radiation therapy that uses high-energy proton beam rather than conventional radiotherapy to irradiate a tumor. The unprecedented demand of proton therapy for the treatment of cancer has set the stage for the market to move ahead at a rapid pace. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells. Proton therapy uses the ionization technique to inhibit cell proliferation. Protons move slowly through the body and interact with electrons and discharge energy.

The number of proton therapy centers is increasing globally. Still, industry experts believe that players will miss out on a majority of cancer patients who can benefit with proton therapy, overlooking a huge multi-Billion-dollar potential market. Globally, the numbers of patients treated with Proton Therapy is very low whereas; the potential candidates for proton therapy are in Millions. IBA dominates the proton therapy market globally. However other players like Varian, Mitsubishi, Mevion, Hitachi etc. have also started to make their presence felt in the market. The increased demand for proton therapy has motivated many prominent cancer centers in the world to provide proton therapy treatment. The number of proton therapy centers worldwide is anticipated to increase year on year, which in turn, will result in more clinical research, better clinician understanding and greater patient awareness of its benefits-which will help drive the further growth.

This is the 3rd edition report on Proton Therapy 麻豆原创 by iGATE RESEARCH. The report titled Proton Therapy 麻豆原创 Outlook - Global Analysis provides a comprehensive assessment of the fast-evolving, high-growth Proton Therapy 麻豆原创.

The 163 Page report with 48 Figures and 21 Tables has been analyzed from 6 View Points

1. Actual and Potential Proton Therapy 麻豆原创 (2009 - 2021)
2. Actual and Potential Candidate for Proton Therapy Treatment (2009 - 2021)
3. Global Total Number of Patients Treated with Proton Therapy - Country Wise
4. United States Proton Therapy - Company Analysis
5. Global Proton Therapy Centers Analysis
6. Proton Therapy 麻豆原创 - Drivers and Challenges

The Countries United States and Japan has been analyzed from 4 View Points

1. Actual and Potential Proton Therapy 麻豆原创 (2009 - 2021)
2. Actual and Potential Candidate for Proton Therapy Treatment (2009 - 2021)
3. List of Proton Therapy Centers
4. Proton Therapy Company Analysis

The Countries South Korea, Europe, China and India has been analyzed from 3 View Points

1. Potential Proton Therapy 麻豆原创 (2009 - 2021)
2. Potential Candidate for Proton Therapy Treatment (2009 - 2021)
3. List of Proton Therapy Centers

United States Proton Therapy - 5 Company Analysis

1. IBA
2. Optivus
3. Hitachi
4. Mevion
5. Varian

Global - List of Proton Therapy Centers Operational and Planned, Specification and Start of Treatment (22 Countries Analyzed)

1. United States
2. Canada
3. Argentina
4. Russia
5. Sweden
6. France
7. Netherlands
8. Italy
9. Poland
10. Germany
11. Czech Republic
12. Switzerland
13. Austria
14. United Kingdom
15. Japan
16. South Korea
17. China
18. India
19. Taiwan
20. Australia
21. Saudi Arabia
22. South Africa

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Global Proton Therapy 麻豆原创 Analysis

2.1 Global Proton Therapy 麻豆原创 - Actual and Potential 麻豆原创 (2009 - 2021)

2.1.1 Global - Proton Therapy 麻豆原创 and Forecast
2.1.2 Global - Potential Proton Therapy 麻豆原创 and Forecast

2.2 Global Proton Therapy Patient Number - Actual and Potential (2009 - 2021)

2.2.1 Global - Patients Treated with Proton Therapy Actual Number and Forecast
2.2.2 Global - Potential Candidate for Proton Therapy Number and Forecast

2.3 Global Total Number of Patients Treated with Proton Therapy - Country Wise

2.4 Global Potential Proton Therapy 麻豆原创 Share Analysis (2009 - 2021)

2.4.1 Global - Potential Proton Therapy 麻豆原创 Share and Forecast
2.4.2 Global - Potential Proton Therapy Candidate Share and Forecast

3. Proton Therapy - Comparative Analysis of Company

4. United States Proton Therapy 麻豆原创 Analysis

4.1 United States Proton Therapy - Actual and Potential 麻豆原创 (2009 - 2021)

4.1.1 United States - Proton Therapy 麻豆原创 and Forecast
4.1.2 United States - Potential Proton Therapy 麻豆原创 and Forecast

4.2 United States Proton Therapy Patients Number - Actual and Potential (2009 - 2021)

4.2.1 United States - Patients Treated with Proton Therapy Actual Number and Forecast
4.2.2 United States - Potential Candidate for Proton Therapy Number and Forecast

4.3 United States - List of Proton Therapy Centers, Start of Treatment, Patient Treated

5. United States Proton Therapy - Company Analysis

5.1 IBA Proton Therapy

5.1.1 IBA Proton Therapy Sales (2007 - 2015)
5.1.2 The Proton Therapy Centers Developed by IBA

5.2 Optivus Proton Therapy

5.2.1 The Proton Therapy Centers Developed by Optivus

5.3 Hitachi Proton Therapy

5.3.1 The Proton Therapy Centers Developed by Hitachi

5.4 Mevion Proton Therapy

5.4.1 The Proton Therapy Centers Developed by Mevion

5.5 Varian Proton Therapy

5.5.1 The Proton Therapy Centers Developed by Varian

6. Japan Proton Therapy 麻豆原创 Analysis

6.1 Japan Proton Therapy - Actual and Potential 麻豆原创 (2005 - 2021)

6.1.1 Japan - Proton Therapy 麻豆原创 and Forecast
6.1.2 Japan - Potential Proton Therapy 麻豆原创 and Forecast

6.2 Japan Proton Therapy Patients Number - Actual and Potential (2005 - 2021)

6.2.1 Japan - Patients Treated with Proton Therapy Actual Number and Forecast
6.2.2 Japan - Potential Candidate for Proton Therapy Number and Forecast

6.3 Japan - List of Proton Therapy Centers, Cost, Start of Treatment, Patient Treated

6.4 Japan Proton Therapy - Company Analysis

6.4.1 The Proton Therapy Centers Developed by Mitsubishi
6.4.2 The Proton Therapy Centers Developed by IBA
6.4.3 The Proton Therapy Centers Developed by Hitachi
6.4.4 The Proton Therapy Centers Developed by Sumitomo Heavy Industries

7. South Korea Potential Proton Therapy 麻豆原创 Analysis (2007 - 2021)

7.1 South Korea - Potential Proton Therapy 麻豆原创 and Forecast
7.2 South Korea - Potential Candidate for Proton Therapy Number and Forecast
7.3 South Korea - List of Proton Therapy Centers, Start of Treatment

8. China Potential Proton Therapy 麻豆原创 Analysis (2009 - 2021)

8.1 China - Potential Proton Therapy 麻豆原创 and Forecast
8.2 China - Potential Candidate for Proton Therapy Number and Forecast
8.3 China - List of Proton Therapy Centers, Start of Treatment

9. India Potential Proton Therapy 麻豆原创 Analysis (2009 - 2021)

9.1 India - Potential Proton Therapy 麻豆原创 and Forecast
9.2 India - Potential Candidate for Proton Therapy Number and Forecast
9.3 India - List of Proton Therapy Centers, Cost, Start of Treatment

10. Europe Potential Proton Therapy 麻豆原创 Analysis (2009 - 2021)

10.1 Europe - Potential Proton Therapy 麻豆原创 and Forecast
10.2 Europe - Potential Candidate for Proton Therapy Number and Forecast

11. Canada Proton Therapy Centers Analysis

12. Argentina Proton Therapy Centers Analysis

13. Europe Proton Therapy Centers Analysis

13.1 Russia Proton Therapy Centers Analysis
13.2 Sweden Proton Therapy Centers Analysis
13.3 France Proton Therapy Centers Analysis
13.4 Netherlands Proton Therapy Centers Analysis
13.5 Italy Proton Therapy Centers Analysis
13.6 Poland Proton Therapy Centers Analysis
13.7 Germany Proton Therapy Centers Analysis
13.8 Czech Republic Proton Therapy Centers Analysis
13.9 Switzerland Proton Therapy Centers Analysis
13.10 Austria Proton Therapy Centers Analysis
13.11 United Kingdom Proton Therapy Centers Analysis

14. South Africa Proton Therapy Centers Analysis

15. Other Asian Country Proton Therapy Centers Analysis

15.1 Taiwan Proton Therapy Centers Analysis
15.2 Australia Proton Therapy Centers Analysis
15.3 Saudi Arabia Proton Therapy Centers Analysis

16. Current Radiation Therapies

16.1 Third Dimensional Conformal Therapy (CRT)
16.2 Image Guided Radiotherapy (IGRT)
16.3 Intensity Modulated Radiotherapy (IMRT)
16.4 Stereotactic Radiotherapy
16.5 Neutron Therapy
16.6 Heavy Ion Radiotherapy
16.7 Proton Therapy

17. Components of a Standard Proton Therapy Center

17.1 Proton Accelerator
17.2 Beam Transport System
17.3 Beam Delivery System
17.3.1 The Passive Scattering Technique
17.3.2 Beam Scanning
17.4 Nozzle
17.4.1 Single ScatteringError! Bookmark not defined.
17.4.2 Double Scattering
17.4.3 Uniform Scanning Nozzle
17.4.4 Pencil Scanning Nozzle
17.5 Treatment Planning System
17.6 Image Viewers
17.7 Patient Positioning System (PPS)
17.8 Human Resource

18. Proton Therapy - Driving Factors

18.1 Technology Advancement
18.1.1 Next-Generation Proton Technique
18.1.2 Technological Advances Make Proton Therapy Centers More Scalable
18.2 Growing Incidence of Cancer Patients
18.3 Proton Therapy Provides Enormous Benefits

19. Proton Therapy - Challenges

19.1 Requires Huge Investment
19.2 Operations Challenges
19.3 More Clinical Evidence Is Needed

List of Tables
List of Tables:

Table 3-1: Proton Therapy - Comparative Analysis of Company, 2014

Table 4-1: United States - List of Proton Therapy Centers Operational and Planned

Table 5-1: United States - IBA Proton Therapy Centers Operational and Planned
Table 5-2: United States - Hitachi Proton Therapy Centers Operational and Planned
Table 5-3: United States - Mevion Proton Therapy Centers Operational and Planned
Table 5-4: United States - Varian Proton Therapy Centers Operational and Planned

Table 6-1: Japan - List of Proton Therapy Centers Operational and Planned
Table 6-2: Japan - Mitsubishi Proton Therapy Centers Operational and Planned
Table 6-3: Japan - IBA Proton Therapy Centers Operational and Planned
Table 6-4: Japan - Hitachi Proton Therapy Centers Operational and Planned
Table 6-5: Japan - Sumitomo Operational Proton Therapy Centers

Table 7-1: South Korea - List of Proton Therapy Centers Operational and Planned

Table 8-1: China - List of Proton Therapy Centers Operational and Planned

Table 9-1: India - List of Planned Proton Therapy Centers

Table 12-1: Argentina - List of Planned Proton Therapy Centers

Table 13-1: Sweden - List of Operational Proton Therapy Centers
Table 13-2: France - List of Proton Therapy Centers Operational and Planned
Table 13-3: Poland - List of Operational Proton Therapy Centers
Table 13-4: Germany - List of Operational Proton Therapy Centers
Table 13-5: Czech Republic - List of Operational Proton Therapy Centers
Table 13-6: United Kingdom - List of Planned Proton Therapy Centers

List of Figures
List of Figures:

Figure 2-1: Global - Proton Therapy 麻豆原创 (Million US$), 2009 - 2015
Figure 2-2: Global - Forecast for Proton Therapy 麻豆原创 (Million US$), 2016 - 2021
Figure 2-3: Global - Potential Proton Therapy 麻豆原创 (Million US$), 2009 - 2015
Figure 2-4: Global - Forecast for Potential Proton Therapy 麻豆原创 (Million US$), 2016 - 2021
Figure 2-5: Global - Patient Treated with Proton Therapy (Number), 2009 - 2015
Figure 2-6: Global - Forecast for Patient Treated with Proton Therapy (Number), 2016 - 2021
Figure 2-7: Global - Potential Candidate for Proton Therapy (Number), 2009 - 2015
Figure 2-8: Global - Forecast for Potential Candidate for Proton Therapy (Number), 2016 - 2021
Figure 2-9: By Country - Total Patients Treated with Charged Particles (Number), 2013
Figure 2-10: Global - Potential Proton Therapy 麻豆原创 Share (Percent), 2009 - 2015
Figure 2-11: Global - Forecast for Potential Proton Therapy 麻豆原创 Share (Percent), 2016 - 2021
Figure 2-12: Global - Potential Proton Therapy Candidate Share (Percent), 2009 - 2015
Figure 2-13: Global - Forecast for Potential Proton Therapy Candidate Share (Percent), 2016 - 2021

Figure 4-1: United States - Proton Therapy 麻豆原创 (Million US$), 2009 - 2015
Figure 4-2: United States - Forecast for Proton Therapy 麻豆原创 (Million US$), 2016 - 2021
Figure 4-3: United States - Potential Proton Therapy 麻豆原创 (Million US$), 2009 - 2015
Figure 4-4: United States - Forecast for Potential Proton Therapy 麻豆原创 (Million US$), 2016 - 2021
Figure 4-5: United States - Patient Treated with Proton Therapy (Number), 2009 - 2015
Figure 4-6: United States - Forecast for Patient Treated with Proton Therapy (Number), 2016 - 2021
Figure 4-7: United States - Potential Candidate for Proton Therapy (Number), 2009 - 2015
Figure 4-8: United States - Forecast for Potential Candidate for Proton Therapy (Number), 2016 - 2021

Figure 5-1: United States - IBA Proton Therapy Sales (Million US$), 2007 - 2015

Figure 6-1: Japan - Proton Therapy 麻豆原创 (Million US$), 2003 - 2015
Figure 6-2: Japan - Forecast for Proton Therapy 麻豆原创 (Million US$), 2016 - 2021
Figure 6-3: Japan - Potential Proton Therapy 麻豆原创 (Million US$), 2005 - 2015
Figure 6-4: Japan - Forecast for Potential Proton Therapy 麻豆原创 (Million US$), 2016 - 2021
Figure 6-5: Japan - Patient Treated with Proton Therapy (Number), 2003 - 2015
Figure 6-6: Japan - Forecast for Patient Treated with Proton Therapy (Number), 2016 - 2021
Figure 6-7: Japan - Potential Candidate for Proton Therapy (Number), 2005 - 2015
Figure 6-8: Japan - Forecast for Potential Candidate for Proton Therapy (Number), 2016 - 2021

Figure 7-1: South Korea - Potential Proton Therapy 麻豆原创 (Million US$), 2007 - 2015
Figure 7-2: South Korea - Forecast for Potential Proton Therapy 麻豆原创 (Million US$), 2016 - 2021
Figure 7-3: South Korea - Potential Candidate for Proton Therapy (Number), 2007 - 2015
Figure 7-4: South Korea - Forecast for Potential Candidate for Proton Therapy (Number), 2016 - 2021

Figure 8-1: China - Potential Proton Therapy 麻豆原创 (Million US$), 2009 - 2015
Figure 8-2: China - Forecast for Potential Proton Therapy 麻豆原创 (Million US$), 2016 - 2021
Figure 8-3: China - Potential Candidate for Proton Therapy (Number), 2009 - 2015
Figure 8-4: China - Forecast for Potential Candidate for Proton Therapy (Number), 2016 - 2021

Figure 9-1: India - Potential Proton Therapy 麻豆原创 (Million US$), 2009 - 2015
Figure 9-2: India - Forecast for Potential Proton Therapy 麻豆原创 (Million US$), 2016 - 2021
Figure 9-3: India - Potential Candidate for Proton Therapy (Number), 2009 - 2015
Figure 9-4: India - Forecast for Potential Candidate for Proton Therapy (Number), 2016 - 2021

Figure 10-1: Europe - Potential Proton Therapy 麻豆原创 (Million US$), 2009 - 2015
Figure 10-2: Europe - Forecast for Potential Proton Therapy 麻豆原创 (Million US$), 2016 - 2021
Figure 10-3: Europe - Potential Candidate for Proton Therapy (Number), 2009 - 2015
Figure 10-4: Europe - Forecast for Potential Candidate for Proton Therapy (Number), 2016 - 2021

Figure 18-1: Global - Number of Patient Diagnosed with Cancer (Million), 2009 - 2015
Figure 18-2: Global - Forecast for Number of Patient Diagnosed with Cancer (Million), 2016 - 2021

Companies Covered

IBA,Varian, Mitsubishi, Mevion, Hitachi

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Enquiry / Request Invoice

Report Inquiry

Do you have more questions related to this market research report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

First Name *

Last Name *

Company *

Email Address *

Phone (Including International Code) *

Report Title *

Do you need invoice for purchasing this report? *

Address 1

Address 2

City/Town

Postal/Zip Code

Country

License Type

Your Inquiry *

CAPTCHA

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

*Please note that the report cover image shown above is for representation purpose only. Actual report cover may vary.

听

Related 麻豆原创 Research Reports

Publication	Price
Degrader-Antibody Conjugates 2024: A Landscape Analysis of Stakeholders, Technologies, Pipeline and Partnering from an Industry Perspective This report provides you with a landscape description and analysis of degrader-antibody conjugate (DAC) stakeholders, platform technologies, development and discovery pipelines and partnering deals from an industry perspective as of September 2024. The emerging novel drug modality of degrader-antibody conjugates represents the convergence of the existing technologies of antibody-drug conjugation and targeted protein degradation to combine the strengths and avoid the limitations of both technologies. DACs combine the specificity of antibodies with the efficiency of degraders of difficult-to-drug protein targets. Degrader-antibody conjugates provide plenty of opportunities for ADC companies to use a novel payload to improve efficacy and the therapeutic window and for targeted protein degradation (TPD) companies to improve cell-specificity, half-life, and drug-like properties. The two main uses for Degrader-Antibody Conjugate therapy...Read more	USD 2,300.00
Global Transcriptomics 麻豆原创 2021-2031 by Component , Technology , Application , End User , and Region: Trend Forecast and Growth Opportunity Global transcriptomics market will reach $ 16,077.8 million by 2031, growing by 10.7% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure. Highlighted with 92 tables and 79 figures, this 175-page report 鈥淕lobal Transcriptomics 麻豆原创 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Region: Trend Forecast and Growth Opportunity鈥� is based on a...Read more	USD 3,180.00
North America Transcriptomics 麻豆原创 2021-2031 by Component , Technology , Application , End User , and Country: Trend Forecast and Growth Opportunity North America transcriptomics market is projected to grow by 10.3% annually in the forecast period and reach $6,124.0 million by 2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure. Highlighted with 32 tables and 43 figures, this 114-page report 鈥淣orth America Transcriptomics 麻豆原创 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and...Read more	USD 2,580.00
Europe Transcriptomics 麻豆原创 2021-2031 by Component , Technology , Application , End User , and Country: Trend Forecast and Growth Opportunity Europe transcriptomics market was valued at $1,479.6 million in 2021 and will grow by 9.9% annually over 2021-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure. Highlighted with 42 tables and 37 figures, this 121-page report 鈥淓urope Transcriptomics 麻豆原创 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity鈥� is based...Read more	USD 2,580.00
Asia Pacific Transcriptomics 麻豆原创 2021-2031 by Component , Technology , Application , End User , and Country: Trend Forecast and Growth Opportunity Asia Pacific transcriptomics market will grow by 13.1% annually with a total addressable market cap of $ 29,787.1 million over 2022-2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure. Highlighted with 39 tables and 46 figures, this 120-page report 鈥淎sia Pacific Transcriptomics 麻豆原创 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and...Read more	USD 2,580.00

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

Disclaimer: 麻豆原创 has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom market research from our website 麻豆原创ResearchReports.com only.

If you are looking for a market research solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us.

麻豆原创